Top Markets
#1 Akedo Akedo +70.44%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.33%
#4 Cross Cross +45.97%
#5 Velvet Velvet +34.78%
#6 Black Phoenix Black Phoenix +34.22%
#7 OVERTAKE OVERTAKE +21.57%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#9 Movement Movement +13.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.14%
Coin of the day
Akedo Akedo
Setări
Limbă
ROMâNă
Monedă
USD
Temă
C4X Discovery Holdings plc C4X Discovery Holdings plc

C4X Discovery Holdings plc

C4XD
Rang în acțiuni #39630
C4X Discovery Holdings plc is a pharmaceutical research firm based in... C4X Discovery Holdings plc is a pharmaceutical research firm based in Manchester, United Kingdom, specializing in the discovery of new drugs. The company leverages advanced proprietary technologies for drug discovery, including Taxonomy3, an innovative computational platform employing unique mathematical algorithms to conduct intricate multi-variable analysis of genetic information. Additionally, Conformetrix provides a technology to precisely determine the three-dimensional structures of unbound drug molecules using experimental data, furnishing medicinal chemists with unparalleled understanding of their physical characteristics and how they behave. Its 4Sight tool further enables the visualization of four-dimensional molecules within a virtual reality environment. The company's development pipeline features several promising candidates: an Orexin-1 receptor antagonist aimed at addictive disorders; an NRF-2 activator targeting various inflammatory conditions; an IL-17A inhibitor for inflammation and autoimmune responses; α4β7 integrin inhibitors developed for inflammatory bowel disease; and MALT-1 inhibitors designed to combat hematological cancers. C4X Discovery has established significant collaborations with key industry players such as Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. Established in 2007, the company initially traded as Schosween 24 plc before adopting its current name, C4X Discovery Holdings plc, in October 2014.
Preț acțiune
$0.16328419
Ultima sincronizare: 2024-04-25
Capitalizare de piață
$411.85K
Schimbare (1 zi)
38.98%
Schimbare (1 an)
0.00%
Țară
GB
Tranzacționează C4X Discovery Holdings plc (C4XD)

Categorie

Healthcare
Venituri pentru C4X Discovery Holdings plc (C4XD)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale C4X Discovery Holdings plc, venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru C4X Discovery Holdings plc din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE